H. Lee Moffitt Cancer Center & Research Institute

Oncology & Cancer

Researchers find dual inhibitor may be safer for CLL patients

Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. One in four new leukemia cases are CLL. Early-stage CLL patients often do not require therapy, but for those with aggressive disease or who have failed ...

page 9 from 28